Assistance options for eligible patients
Since we first started providing access and reimbursement support over 20 years ago, Genentech has helped more than 1.5 million patients access the Genentech medicines they need.
If your patients have financial concerns related to their Genentech
medicine, we may be able to help.
CellCept® Co-pay Card Program†
Commercial patients who are eligible for the CellCept® Co-pay Card Program could:
- Reduce their out-of-pocket costs to as little as $15 per monthly co-pay, regardless of their annual income level
- Receive a maximum co-pay assistance of $10,000 per year
Enroll your patients
today or learn more about the CellCept® Co-pay Card
Program by calling 1-833-CellCept (1-833-235-5237) from 8:00 AM to
8:00 PM ET (Mon-Fri) .
Genentech® Access to Care Foundation (GATCF)‡
GATCF provides free medicine to eligible patients who are uninsured, rendered uninsured by payer denial, or underinsured. To qualify, patients must meet specific criteria.
For more information on GATCF, please call 1-888-754-7651 9:00 am to 7:00 pm ET (Mon-Fri).
To enroll in GATCF, please fax the following forms to Genentech® Access Solutions (fax 1-800-305-1830):
- A Patient Notice of Request for Transmission of Health Information (PAN) form signed by the patient. Download English or Spanish.
- A completed Statement of Medical Necessity (SMN) with appropriate services indicated. Download English.
*CellCept is used in combination with cyclosporine and
†By using the CellCept® Copay Card Program, the patient acknowledges and confirms that, at the time of usage, (s)he is currently eligible and meets the criteria set forth in the terms and conditions described.
This CellCept® Co-pay Program is valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid, Medigap, Veteran’s Affairs (VA), Department of Defense (DoD), TRICARE or any other federal or state government program to pay for their medications are not eligible. The Program is not valid for medications that are eligible to be reimbursed in their entirety by private insurance plans or other programs.
Under the Program, the patient will pay a co-pay. After reaching the maximum Program benefit, the patient will be responsible for all Out-of-Pocket costs. This Program is not health insurance or a benefit plan. The Program does not obligate the use of any specific product or provider. Patients receiving assistance from charitable assistance programs (such as Genentech Patient Foundation) are not eligible. The Co-pay benefit cannot be combined with any other rebate, free trial, or similar offer for the medication. No party may seek reimbursement for all or any part of the benefit received through this Program.
The Program may be accepted by participating pharmacies, physician offices, or hospitals. Once enrolled, this Program will not honor claims with date of service or medication dispensing that precede Program enrollment by more than 120 days. Use of this Program must be consistent with all relevant health insurance requirements. Participating patients, pharmacies, physician offices, and hospitals are responsible for reporting the receipt of all Program benefits as required by any insurer or by law. Program benefits may not be sold, purchased, traded, or offered for sale, purchase, or trade.
The patient or their guardian must be 18 years or older for the
patient to be eligible. This Program is only valid in the United
States and U.S. Territories. This Program is void where prohibited by
law and shall follow state restrictions in relation to AB-rated
generic equivalents (e.g. MA, CA) where applicable. Program
eligibility is contingent upon the patient’s ability to meet and
maintain all requirements set forth by the Program. Genentech reserves
the right to rescind, revoke, or amend the Program without notice at
‡Genentech does not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance. The foundations to which we refer patients are not exhaustive or indicative of Genentech's endorsement or financial support. There may be other foundations to support the patient's disease state.
Help your patients access brand-name medicine
Your commercially insured patients may pay as little as $15 per monthly co-pay with the CellCept® Co-pay Card Program.